Filtered By:
Source: ScienceDaily Headlines
Condition: Cholesterol
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 25 results found since Jan 2013.
Over 80s often over-treated for stroke prevention
People in their 80s are often prescribed drugs to ward off a stroke when the risk of a stroke is not that high and the drugs have other side effects, suggest a new medical article. Statins and antihypertensive drugs were the most commonly prescribed cardiovascular drugs in the UK in 2006. And they are widely prescribed to patients in their 80s to ward off stroke. This is despite the fact that the research shows that, by this age, high blood pressure is not a key contributory risk factor, and high cholesterol has little effect on stroke risk, overall.
Source: ScienceDaily Headlines - February 27, 2014 Category: Science Source Type: news
Drinking alcohol several times a week increases risk of stroke mortality
Consuming alcohol more frequently than twice a week increases the risk of stroke mortality in men, according to a study. The results show that the effects of alcohol are not limited to the amount consumed, but also the frequency of drinking matters. Other significant risk factors for stroke include elevated blood pressure, coronary artery disease, heart failure, atrial fibrillation, diabetes, smoking, overweight, asymptomatic carotid artery stenosis, and elevated cholesterol levels.
Source: ScienceDaily Headlines - March 19, 2014 Category: Science Source Type: news
Severe sleep apnea linked to increased risk of stroke, cancer, death
Moderate to severe obstructive sleep apnea is independently associated with an increased risk of stroke, cancer and death. Results of the 20-year follow-up study show that people with moderate to severe obstructive sleep apnea were four times more likely to die (hazard ratio = 4.2), nearly four times more likely to have a stroke (HR = 3.7), three times more likely to die from cancer (HR = 3.4), and 2.5 times more likely to develop cancer. Results were adjusted for potential confounding factors such as body mass index, smoking status, total cholesterol and blood pressure.
Source: ScienceDaily Headlines - April 14, 2014 Category: Science Source Type: news
Statin use during hospitalization for hemorrhagic stroke associated with improved survival
This study was conducted by the same researchers who recently discovered that the use of cholesterol-lowering statins can improve survival in victims of ischemic stroke.
Source: ScienceDaily Headlines - September 22, 2014 Category: Science Source Type: news
Statin drugs reduce infection risk in stroke patients, report suggests
Statin drugs can dramatically lower the risk of infections in stroke patients, report researchers. Patients on statins upon admission to hospital, or early in their stay, had significantly lower risk for developing infections than those put on statins later in their hospitalization or not at all. These findings remained strong after being controlled for other possible influences like the severity of strokes, age and the presence of other conditions like diabetes.
Source: ScienceDaily Headlines - June 16, 2016 Category: Science Source Type: news
Molecular therapy set to protect at-risk patients against heart attack and stroke
Even a single dose of a specific ribonucleic acid molecule, known as a small interfering RNA (siRNA), offers patients at high risk of cardiovascular disease long-lasting protection against high LDL cholesterol -- one of the main risk factors for heart attack and stroke -- conclude researchers.
Source: ScienceDaily Headlines - March 30, 2017 Category: Science Source Type: news
Blood pressure control, lifestyle changes key to preventing subsequent strokes
Controlling blood pressure, cholesterol and irregular heart rhythms are key to stroke survivors avoiding another stroke. Updated guidelines emphasize lifestyle management, including diet, exercise and weight management. Other important updates affect management of narrowed neck arteries and irregular heartbeat.
Source: ScienceDaily Headlines - May 1, 2014 Category: Science Source Type: news
Cholesterol-lowering drugs may reduce cardiovascular death in type 2 diabetes
Heart disease and stroke are the leading causes of death and disability among people with Type 2 diabetes. In fact, at least 65 percent of people with diabetes die from some form of heart disease or stroke. However, a new study suggests that the use of cholesterol-lowering statins may help prolong the lives of people with diabetic cardiovascular disease.
Source: ScienceDaily Headlines - July 16, 2014 Category: Science Source Type: news
Early atherosclerotic plaques in vessel wall regress completely when cholesterol levels are lowered
Early but not advanced forms of atherosclerotic plaques in the vessel wall disappear when the levels of 'bad' cholesterol are lowered, according to a study in mice. The findings indicate that preventative cholesterol-lowering treatment could prevent more advanced, clinically relevant plaque to develop. Almost half of all deaths worldwide are caused by strokes and heart attacks. The main underlying cause is atherosclerosis, where fat accumulates in the blood vessel walls in the so-called plaques. Atherosclerosis is a progressive disease where advanced and unstable plaques develop over time. When these plaques burst a blood ...
Source: ScienceDaily Headlines - February 28, 2014 Category: Science Source Type: news
New guidelines deem 13 million more Americans eligible for statins
New guidelines for using statins to treat high cholesterol and prevent cardiovascular disease are projected to result in 12.8 million more U.S. adults taking the drugs, according to a new research. The new guidelines expand the criteria for statin use to include people whose 10-year risk of developing cardiovascular disease, including stroke, is elevated based on a risk-assessment score.
Source: ScienceDaily Headlines - March 19, 2014 Category: Science Source Type: news
Medication does not reduce risk of recurrent cardiac events among patients with diabetes
Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type 2 diabetes and recent heart attack or unstable angina, according to a study.
Source: ScienceDaily Headlines - March 30, 2014 Category: Science Source Type: news
Chronic stress heightens vulnerability to diet-related metabolic risk
Highly stressed people who eat a lot of high-fat, high-sugar food are more prone to health risks than low-stress people who eat the same amount of unhealthy food, new research finds for the first time. Metabolic syndrome is a cluster of abnormalities -- increased blood pressure, a high blood sugar level, excess body fat around the waist and abnormal cholesterol levels -- that occur together, increasing a person's risk of heart disease, stroke and diabetes.
Source: ScienceDaily Headlines - April 29, 2014 Category: Science Source Type: news
Statins for kidney disease patients: Protection for heart but no effects on kidneys
For patients with chronic kidney disease, statin treatment appears to lower LDL cholesterol, decrease the risk of heart disease and stroke, and has no impact on the development of kidney failure, research concluded. Investigators have said that statin treatment is safe and well tolerated for those with chronic kidney disease.
Source: ScienceDaily Headlines - May 1, 2014 Category: Science Source Type: news
New driver of atherosclerosis offers potential as therapeutic target
A new driver of atherosclerosis has been identified by researchers. Atherosclerosis is characterized by the build-up of lesions (or plaques) formed from lipids, such as cholesterol and fatty acids. Ruptured plaques can partially or completely block blood flow, potentially leading to a heart attack or stroke.
Source: ScienceDaily Headlines - June 19, 2014 Category: Science Source Type: news
Report urges individualized, cholesterol-targeted approach to heart disease, stroke
A recent guideline for using statins to reduce atherosclerotic cardiovascular disease has wavered too far from the simple cholesterol goals that have saved thousands of lives in the past decade, and doesn't adequately treat patients as individuals, experts say.
Source: ScienceDaily Headlines - September 15, 2014 Category: Science Source Type: news
